Loading...
| A02256 | Pages: NA | Dec 2021 | 5671 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Nasal Drug Delivery Technologies Market
Request Now !Nasal delivery is used as a treatment of local infection in the nasal course & paranasal sinuses such as allergic & non-allergic sinusitis & rhinitis. The nasal drug delivery technique is used as to mitigate the problem of slow absorption of drugs, degradation before reaching the target site, and poor bioavailability. In addition, it helps in resolving issues related to the gastrointestinal tract and first-pass metabolism in liver. The significance of the nasal airway technology is to protect the lungs from hazardous contacts, rather than acting as a delivery route for drugs.
The global nasal drug delivery technology market is driven by rise in demand for alternative routes of drug delivery such as nasal sprays, increase in emphasis on pediatric & geriatric patients, growth in need of easy administration & better efficacy products, rise in demand for home healthcare devices, surge in adoption of self-administration practices, and advanced healthcare set-up. However, patents expiry of several drugs and side effects pertaining to drugs, such as nausea, irritation, and infections, restrain the market growth. Conversely, the development of OTC drugs by many pharmaceutical companies provides lucrative opportunities for market growth, especially for nasal drops and sprays sold as generic OTC drugs.
The global nasal drug delivery technology market is segmented on the basis of dosage form, container, system, therapeutic application, end user, and region. Based on dosage form, it is categorized into sprays, drops & liquids, powders, gels, and others. On the basis of container, it is bifurcated into pressurized containers and non-pressurized containers. Based on system, it is divided into multi-dose systems, bi-dose systems, and unit-dose systems. Based on therapeutic application, it is classified into allergic & non-allergic rhinitis, nose congestion, vaccination, and others. Based on end user, it is divided into home care settings and hospitals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include Merck & Co., Inc., Novartis AG, Johnson & Johnson, Pfizer Inc., AstraZeneca, AptarGroup, Inc., GlaxoSmithKline plc., Aegis Therapeutics LLC., and Becton, Dickinson and Company.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. PATENT ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY DOSAGE FORM
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. NASAL SPRAYS
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. DROPS & LIQUIDS
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. POWDERS
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. GELS
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY CONTAINER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. PRESSURIZED CONTAINERS
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. NON-PRESSURIZED CONTAINERS
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY SYSTEM
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. MULTI-DOSE SYSTEMS
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. BI-DOSE SYSTEMS
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. UNIT-DOSE SYSTEMS
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY THERAPEUTIC APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. ALLERGIC & NON-ALLERGIC RHINITIS
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. NOSE CONGESTION
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. VACCINATION
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country
7.5. OTHER THERAPEUTIC APPLICATIONS
7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country
CHAPTER 8 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY END USER
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. HOME CARE SETTINGS
8.2.1. Market size and forecast, by region
8.2.2. Market analysis, by country
8.3. HOSPITALS & CLINICS
8.3.1. Market size and forecast, by region
8.3.2. Market analysis, by country
CHAPTER 9 NASAL DRUG DELIVERY TECHNOLOGIES MARKET, BY REGION
9.1. OVERVIEW
9.2. NORTH AMERICA
9.2.1. Key market trends, growth factors and opportunities
9.2.2. North America nasal drug delivery technologies market, by country
9.2.2.1. U.S. nasal drug delivery technologies market
9.2.2.1.1. U.S. market, by dosage form
9.2.2.1.2. U.S. market, by container
9.2.2.1.3. U.S. market, by system
9.2.2.1.4. U.S. market, by therapeutic application
9.2.2.1.5. U.S. market, by end user
9.2.2.2. Canada nasal drug delivery technologies market
9.2.2.2.1. Canada market, by dosage form
9.2.2.2.2. Canada market, by container
9.2.2.2.3. Canada market, by system
9.2.2.2.4. Canada market, by therapeutic application
9.2.2.2.5. Canada market, by end user
9.2.2.3. Mexico nasal drug delivery technologies market
9.2.2.3.1. Mexico market, by dosage form
9.2.2.3.2. Mexico market, by container
9.2.2.3.3. Mexico market, by system
9.2.2.3.4. Mexico market, by therapeutic application
9.2.2.3.5. Mexico market, by end user
9.2.3. North America nasal drug delivery technologies market, by dosage form
9.2.4. North America nasal drug delivery technologies market, by container
9.2.5. North America nasal drug delivery technologies market, by system
9.2.6. North America nasal drug delivery technologies market, by therapeutic application
9.2.7. North America nasal drug delivery technologies market, by end user
9.3. EUROPE
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Europe nasal drug delivery technologies market, by country
9.3.2.1. Germany nasal drug delivery technologies market
9.3.2.1.1. Germany market, by dosage form
9.3.2.1.2. Germany market, by container
9.3.2.1.3. Germany market, by system
9.3.2.1.4. Germany market, by therapeutic application
9.3.2.1.5. Germany market, by end user
9.3.2.2. France nasal drug delivery technologies market
9.3.2.2.1. France market, by dosage form
9.3.2.2.2. France market, by container
9.3.2.2.3. France market, by system
9.3.2.2.4. France market, by therapeutic application
9.3.2.2.5. France market, by end user
9.3.2.3. UK nasal drug delivery technologies market
9.3.2.3.1. UK market, by dosage form
9.3.2.3.2. UK market, by container
9.3.2.3.3. UK market, by system
9.3.2.3.4. UK market, by therapeutic application
9.3.2.3.5. UK market, by end user
9.3.2.4. Italy nasal drug delivery technologies market
9.3.2.4.1. Italy market, by dosage form
9.3.2.4.2. Italy market, by container
9.3.2.4.3. Italy market, by system
9.3.2.4.4. Italy market, by therapeutic application
9.3.2.4.5. Italy market, by end user
9.3.2.5. Spain nasal drug delivery technologies market
9.3.2.5.1. Spain market, by dosage form
9.3.2.5.2. Spain market, by container
9.3.2.5.3. Spain market, by system
9.3.2.5.4. Spain market, by therapeutic application
9.3.2.5.5. Spain market, by end user
9.3.2.6. Rest of Europe nasal drug delivery technologies market
9.3.2.6.1. Rest of Europe market, by dosage form
9.3.2.6.2. Rest of Europe market, by container
9.3.2.6.3. Rest of Europe market, by system
9.3.2.6.4. Rest of Europe market, by therapeutic application
9.3.2.6.5. Rest of Europe market, by end user
9.3.3. Europe nasal drug delivery technologies market, by dosage form
9.3.4. Europe nasal drug delivery technologies market, by container
9.3.5. Europe nasal drug delivery technologies market, by system
9.3.6. Europe nasal drug delivery technologies market, by therapeutic application
9.3.7. Europe nasal drug delivery technologies market, by end user
9.4. ASIA-PACIFIC
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Asia-Pacific nasal drug delivery technologies market, by country
9.4.2.1. Japan nasal drug delivery technologies market
9.4.2.1.1. Japan market, by dosage form
9.4.2.1.2. Japan market, by container
9.4.2.1.3. Japan market, by system
9.4.2.1.4. Japan market, by therapeutic application
9.4.2.1.5. Japan market, by end user
9.4.2.2. China nasal drug delivery technologies market
9.4.2.2.1. China market, by dosage form
9.4.2.2.2. China market, by container
9.4.2.2.3. China market, by system
9.4.2.2.4. China market, by therapeutic application
9.4.2.2.5. China market, by end user
9.4.2.3. Australia nasal drug delivery technologies market
9.4.2.3.1. Australia market, by dosage form
9.4.2.3.2. Australia market, by container
9.4.2.3.3. Australia market, by system
9.4.2.3.4. Australia market, by therapeutic application
9.4.2.3.5. Australia market, by end user
9.4.2.4. India nasal drug delivery technologies market
9.4.2.4.1. India market, by dosage form
9.4.2.4.2. India market, by container
9.4.2.4.3. India market, by system
9.4.2.4.4. India market, by therapeutic application
9.4.2.4.5. India market, by end user
9.4.2.5. South Korea nasal drug delivery technologies market
9.4.2.5.1. South Korea market, by dosage form
9.4.2.5.2. South Korea market, by container
9.4.2.5.3. South Korea market, by system
9.4.2.5.4. South Korea market, by therapeutic application
9.4.2.5.5. South Korea market, by end user
9.4.2.6. Rest of Asia-Pacific nasal drug delivery technologies market
9.4.2.6.1. Rest of Asia-Pacific market, by dosage form
9.4.2.6.2. Rest of Asia-Pacific market, by container
9.4.2.6.3. Rest of Asia-Pacific market, by system
9.4.2.6.4. Rest of Asia-Pacific market, by therapeutic application
9.4.2.6.5. Rest of Asia-Pacific market, by end user
9.4.3. Asia-Pacific nasal drug delivery technologies market, by dosage form
9.4.4. Asia-Pacific nasal drug delivery technologies market, by container
9.4.5. Asia-Pacific nasal drug delivery technologies market, by system
9.4.6. Asia-Pacific nasal drug delivery technologies market, by therapeutic application
9.4.7. Asia-Pacific nasal drug delivery technologies market, by end user
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. LAMEA nasal drug delivery technologies market, by country
9.5.2.1. Brazil nasal drug delivery technologies market
9.5.2.1.1. Brazil market, by dosage form
9.5.2.1.2. Brazil market, by container
9.5.2.1.3. Brazil market, by system
9.5.2.1.4. Brazil market, by therapeutic application
9.5.2.1.5. Brazil market, by end user
9.5.2.2. Saudi Arabia nasal drug delivery technologies market
9.5.2.2.1. Saudi Arabia market, by dosage form
9.5.2.2.2. Saudi Arabia market, by container
9.5.2.2.3. Saudi Arabia market, by system
9.5.2.2.4. Saudi Arabia market, by therapeutic application
9.5.2.2.5. Saudi Arabia market, by end user
9.5.2.3. South Africa nasal drug delivery technologies market
9.5.2.3.1. South Africa market, by dosage form
9.5.2.3.2. South Africa market, by container
9.5.2.3.3. South Africa market, by system
9.5.2.3.4. South Africa market, by therapeutic application
9.5.2.3.5. South Africa market, by end user
9.5.2.4. Rest of LAMEA nasal drug delivery technologies market
9.5.2.4.1. Rest of LAMEA market, by dosage form
9.5.2.4.2. Rest of LAMEA market, by container
9.5.2.4.3. Rest of LAMEA market, by system
9.5.2.4.4. Rest of LAMEA market, by therapeutic application
9.5.2.4.5. Rest of LAMEA market, by end user
9.5.3. LAMEA nasal drug delivery technologies market, by dosage form
9.5.4. LAMEA nasal drug delivery technologies market, by container
9.5.5. LAMEA nasal drug delivery technologies market, by system
9.5.6. LAMEA nasal drug delivery technologies market, by therapeutic application
9.5.7. LAMEA nasal drug delivery technologies market, by end user
CHAPTER 10 COMPANY PROFILES
10.1. MERCK & CO., INC.
10.1.1. Operating business segments
10.1.2. Business performance
10.1.3. Key strategic moves and developments
10.2. NOVARTIS AG
10.2.1. Operating business segments
10.2.2. Business performance
10.2.3. Key strategic moves and developments
10.3. JOHNSON & JOHNSON
10.3.1. Operating business segments
10.3.2. Business performance
10.3.3. Key strategic moves and developments
10.4. PFIZER, INC.
10.4.1. Operating business segments
10.4.2. Business performance
10.4.3. Key strategic moves and developments
10.5. ASTRAZENECA PLC.
10.5.1. Operating business segments
10.5.2. Business performance
10.5.3. Key strategic moves and developments
10.6. APTARGROUP INC.
10.6.1. Operating business segments
10.6.2. Business performance
10.6.3. Key strategic moves and developments
10.7. GLAXOSMITHKLINE PLC.
10.7.1. Operating business segments
10.7.2. Business performance
10.7.3. Key strategic moves and developments
10.8. AEGIS THERAPEUTICS LLC
10.8.1. Operating business segments
10.8.2. Business performance
10.8.3. Key strategic moves and developments
10.9. BECTON, DICKINSON AND COMPANY
10.9.1. Operating business segments
10.9.2. Business performance
10.9.3. Key strategic moves and developments
10.10. 3M COMPANY
10.10.1. Operating business segments
10.10.2. Business performance
10.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
